NiFe Hydrogenase

Overview

NiFe-hydrogenase (also called [Ni-Fe] hydrogenase or nickel-iron hydrogenase) is a class of enzymes that catalyze reversible hydrogen (H₂) oxidation. The active site contains both nickel (Ni) and iron (Fe) metal atoms arranged in a sophisticated bimetallic cluster. The reaction catalyzed is:

``` H₂ ↔ 2H⁺ + 2e⁻ ```

In the forward direction, H₂ is oxidized to protons and electrons, releasing energy that powers ATP synthesis (in some bacteria). In the reverse direction, protons are reduced to H₂ (used for energy storage or stress relief).

NiFe-hydrogenases are found in:

NiFe-hydrogenases are virulence factors enabling anaerobic persistence and interkingdom cooperation (H₂ produced by one organism consumed by another in the same biofilm).

Mechanism

Active site structure:

The NiFe-hydrogenase active site is a bi-metallic cluster containing:

  • Nickel (Ni) — the main catalytic site
  • Iron (Fe) — coordinates the substrate and facilitates electron transfer
  • Bridging ligands: cyanide (CN⁻) and carbonyl (CO) groups stabilize the Fe center
  • Nickel coordination: Histidine and cysteine residues

The bimetallic arrangement is critical: neither metal alone is sufficient; both Ni and Fe are required for catalysis.

Catalytic cycle:

``` H₂ binding → heterolytic cleavage of H-H → H⁺ released to solvent → 2e⁻ transferred to electron transport chain (quinone, NAD⁺, etc.) ```

This is energetically favorable under anaerobic or microaerophilic conditions (when dissolved O₂ is low).

Nickel and iron acquisition:

  • Bacteria must acquire both Ni and Fe from the environment
  • H. pylori: Uses NixA (nickel permease) and iron transporters; competes with host transferrin and lactoferrin for iron
  • Sulfate-reducing bacteria: Acquire metals from sediment or gut contents; highly dependent on iron and nickel availability

Role in Disease

H. pylori persistence in the microaerophilic gastric niche:

H. pylori lives in the mucus layer where O₂ is scarce but not zero (microaerophilic, ~1–5% O₂). Under these conditions:

  • Oxidative phosphorylation is insufficient (not enough O₂ for efficient ATP synthesis)
  • H₂ oxidation via NiFe-hydrogenase becomes critical — provides additional ATP and electrons for reducing O₂ via cytochrome c oxidase
  • Without NiFe-hydrogenase: H. pylori cannot thrive in low-O₂ niches; burden is reduced

Related conditions:

  • gastric ulcer, gastric adenocarcinoma — H. pylori NiFe-hydrogenase enables persistent colonization
  • Methane-predominant SIBO (small intestinal bacterial overgrowth): M. smithii NiFe-hydrogenase consumes H₂ produced by fermentative bacteria; enables overgrowth by reducing H₂-induced inhibition

Interkingdom cooperation in biofilms:

In polymicrobial biofilms (e.g., cystic fibrosis lung, diabetic foot ulcers):

  • Fermentative bacteria (e.g., bacteroides) produce H₂ as a metabolic byproduct
  • M. smithii or sulfate-reducers (via NiFe-hydrogenase) consume H₂
  • This removes H₂ (which inhibits fermentation), enabling primary fermenters to proliferate
  • The biofilm becomes self-sustaining; difficult to eradicate

Metal Connections

NiFe-hydrogenase is a paradigm for Primitive 4: Metal Dependencies as Achilles' Heels:

Dual metal requirement:

  • Bacteria cannot substitute monometallic hydrogenases if both Ni and Fe are depleted
  • Simultaneous Ni and Fe starvation is more potent than either metal alone
  • This is clinically relevant for H. pylori and dysbiotic methanogens

Nickel availability in the stomach:

  • H. pylori gastric infection depends on both NiFe-hydrogenase AND nickel urease
  • Both enzymes require Ni; nickel-limited conditions → both virulence pathways compromised
  • Therapeutic target: Nickel chelation or dietary nickel restriction in H. pylori-infected patients

Iron availability and bacterial competition:

Sulfate-reducer ecology:

  • Sulfate-reducing bacteria (via NiFe-hydrogenase) thrive in iron-rich, anaerobic environments
  • They produce H₂S, which precipitates bioavailable zinc and iron, creating further metal dysbiosis
  • This is a self-amplifying pathological cycle: iron overload → H₂S production → further metal dysbiosis

Connections

Related enzymes:

  • nickel urease — complementary H. pylori virulence factor; both require nickel
  • [FeFe]-hydrogenases — simpler hydrogenases containing only iron; less common in pathogens
  • Cytochrome c oxidase — uses H₂ electrons; works in tandem with NiFe-hydrogenase in H. pylori

Related organisms:

  • H. pylori — primary pathogen expressing NiFe-hydrogenase; microaerophilic survival
  • M. smithii — methane-producing archaeon; H₂ consumer in the gut
  • Sulfate-reducing bacteria (desulfovibrio, ) — H₂-dependent sulfate reducers in anaerobic environments
  • bacteroides — H₂ producers in fermentation; work synergistically with H₂-consuming methanogens

Related concepts:

  • hypoxia/ — low-O₂ niches where NiFe-hydrogenase enables survival
  • nutritional immunity — nickel and iron sequestration as defenses against NiFe-hydrogenase-dependent pathogens
  • biofilm — interkingdom cooperation via H₂ consumption
  • — H. pylori NiFe-hydrogenase enables co-persistence with other microaerophiles
  • metal-cofactor-dependency — dual-metal requirement is a strategic vulnerability

Related metals and proteins:

  • nickel — essential cofactor; nickel depletion disables NiFe-hydrogenase
  • iron — essential cofactor; iron sequestration limits H. pylori persistence
  • — product of sulfate-reducer NiFe-hydrogenase coupled to sulfate reduction; dysbiotic byproduct

Disease pages:

  • , — H. pylori-driven diseases where NiFe-hydrogenase enables microaerophilic survival
  • SIBO, methane-predominant dysbiosis — conditions with elevated M. smithii and H₂-consuming activity

References (8)

  1. Benoit SL, Bhatt RJ, Maier RJ (2021). The nickel-chelator dimethylglyoxime inhibits human amyloid beta peptide in vitro aggregation. Scientific Reports. doi:10.1038/s41598-021-86060-1
  2. Alexander C. Razavi, Kaitlin S. Potts, Tanika N. Kelly et al. (2019). Sex, gut microbiome, and cardiovascular disease risk. Biology of Sex Differences. doi:10.1186/s13293-019-0240-z
  3. Monisha Jaishankar, Tenzin Tseten, Naresh Anbalagan et al. (2014). Toxicity, Mechanism and Health Effects of Some Heavy Metals. Interdisciplinary Toxicology. doi:10.2478/intox-2014-0009
  4. Jhommara Bautista, Walter D. Cardona-Maya, Kelly Gancino-Guevara et al. (2025). Bautista 2025 — Reprogramming Prostate Cancer Through the Microbiome. Frontiers in Medicine. doi:10.3389/fmed.2025.1690498
  5. Shuya Lv, Jingrong Huang, Yadan Luo et al. (2024). Lv 2024 — Gut Microbiota Is Involved in Male Reproductive Function: A Review. Frontiers in Microbiology. doi:10.3389/fmicb.2024.1371667
  6. Yuqi Wu, Oscar Wong, Sizhe Chen et al. (2025). Wu 2025 — Distinct Diet-Microbiome Associations in Autism Spectrum Disorder. Nature Communications. doi:10.1038/s41467-025-67711-7
  7. Swierc J, Drzymala S, Wozniak D et al. (2022). The influence of nickel on intestinal microbiota disturbances. Pomeranian Journal of Life Sciences. doi:10.21164/pomjlifesci.810
  8. Babak Khorsand, Hamid Asadzadeh Aghdaei, Ehsan Nazemalhosseini-Mojarad et al. (2022). Khorsand 2022 — Overrepresentation of Enterobacteriaceae and Escherichia coli is the major gut microbiome signature in Crohn's and UC: comprehensive metagenomic analysis of IBDMDB datasets. Frontiers in Cellular and Infection Microbiology. doi:10.3389/fcimb.2022.1015890